Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
U.S. energy behemoth ExxonMobil Corporation’s (XOM - Analyst Report) third quarter 2012 earnings of $2.09 per share (excluding special items) beat the Zacks Consensus Estimate of $1.96 on stronger refining margins and lower costs (down by approximately 7.7% year over year). However, the company stumbled on the production front, generating lower volumes, aggravated by weak commodity prices. Earnings were thus down by almost 2% from the year-ago profit level of $2.13 a share.
Total revenue in the quarter decreased 7.7% year over year to $115.7 billion, but surpassed the Zacks Consensus Estimate of $110.0 billion.
Operational Performance
Upstream: Quarterly earnings of the segment were $6.0 billion, down 28.8% from $8.4 billion a year ago. The decline was primarily due to lower sales volumes and lower oil/natural gas realizations.
Production averaged 3.960 million barrels of oil-equivalent per day (MMBOE/d) in the quarter, down 7.5% year over year. When adjusted for the impact of entitlement volumes and OPEC quota restrictions, production was down by 2.9% from the prior-year quarter.
Liquid production experienced a downfall of 5.9% year over year to 2.116 million barrels per day due to field decline. This was partially offset by the stepping up of Angola and Nigeria ventures.
Again, field decline resulted in the natural gas production slump of more than 9% on an annualized basis.
Downstream: The segment recorded profit of $3.2 billion in the third quarter of 2012 as against $1.6 billion in the year-ago period, mainly due to margin improvement. Asset sale gains and lower operating expenses also contributed to the increase.
ExxonMobil's refinery throughput averaged 4.9 million barrels per day (MMBPD), down by 5.8% from the year-earlier level of 5.2 MMBPD.
Chemical: This unit contributed $0.8 billion to the company’s profits, down from the year-earlier level of $1.0 billion. The underperformance was mainly due to adverse foreign exchange effects, poor margins and lower sales.
Financials
During the quarter, ExxonMobil generated cash flow from operations and asset sales of $14.0 billion and returned more than $7.6 billion to shareholders through dividends/share purchases. It also repurchased 58 million shares of its own stock in the third quarter for $5.1 billion. Capital spending during the quarter was $9.2 billion.
Our Take
ExxonMobil shares currently retain a Zacks #3 Rank, which translates into a short-term Hold rating. We also maintain our long-term Neutral recommendation on the stock.
We believe that ExxonMobil is the world’s best-run integrated oil company given its track record of superior return on capital employed. The company boasts of diversified operations across the world with several new projects coming online through 2013.
ExxonMobil’s strength is in its balanced operations, strong financial flexibility and continuous improvement on efficiency and cost control. The company’s efforts to build an unconventional resource portfolio both in North America and overseas aims at increasing production through increased exposure to large energy resources with long reserve life and low field declines. Despite the collapse in natural gas prices, ExxonMobil expects unconventional gas to play a dominant role in future supplies owing to the rapid decline in conventional production.
Recently, its Canadian unit − ExxonMobil Canada − agreed to acquire Calgary-based oil and gas driller Celtic Exploration Ltd., in a move towards expanding its footprint in the unconventional energy plays in North America.
Again, in September, the company and its subsidiary, XTO Energy Inc, entered into an agreement with Denbury Onshore, LLC, a subsidiary of oil and natural gas company Denbury Resources Inc. (DNR - Analyst Report), to acquire all of Denbury’s Bakken shale assets. The deal will increase its production in the Bakken oil shale region.
However, we remain skeptical due to the company’s continued disappointing production trend, which decreased for five quarters in a row. We see ExxonMobil struggling to grow production volumes over time.
Get the full Analyst Report on DNR - FREE
Get the full Analyst Report on XOM - FREE